Genome Compiler raised €5.8M in a Series A round in Jun 2015. The company is based in Tel Aviv-Yafo, Israel. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €5.8M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
